EUVIMEDEUVIMED entdecken
Crossref

Strategies for DPYD testing prior to fluoropyrimidine chemotherapy in the US

Tabea Tracksdorf, D Max Smith, Skyler Pearse, Emily J Cicali, Christina L Aquilante, Stuart A Scott, Teresa T Ho, Jai N Patel, J Kevin Hicks, Daniel L Hertz

Supportive Care in Cancer · 2024

DOI: 10.1007/s00520-024-08674-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Supportive Care in Cancer, 2024. Verfasst von Tabea Tracksdorf und 9 weiteren Autor:innen. Beteiligte Einrichtung: Deparment of Clinical Pharmacy, University of Michigan College of Pharmacy, 428 Church St, Room 2560C, Ann Arbor, MI, 48109-1065, USA. Hauptthemen laut MEDLINE: Dihydrouracil Dehydrogenase (NADP), Dihydropyrimidine Dehydrogenase Deficiency. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 44 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dihydrouracil Dehydrogenase (NADP)Dihydropyrimidine Dehydrogenase DeficiencyHumansUnited StatesNeoplasmsAntimetabolites, AntineoplasticSurveys and QuestionnairesFluorouracil

Stichwörter der Autor:innen

DPYDClinical implementationFluoropyrimidinesOncologyPharmacogeneticsSurvey

Substanzen

Dihydrouracil Dehydrogenase (NADP)Antimetabolites, AntineoplasticFluorouracil

Autor:innen und Institutionen

  • Deparment of Clinical Pharmacy, University of Michigan College of Pharmacy, 428 Church St, Room 2560C, Ann Arbor, MI, 48109-1065, USA.
  • Department of Oncology, Georgetown University Medical Center, Washington, DC, USA.
  • MedStar Health, Columbia, MD, USA.
  • Health Behavior and Health Education, School of Public Health, University of Michigan, Ann Arbor, MI, USA.
  • Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Gainesville, FL, USA.
  • Center for Pharmacogenomics and Precision Medicine, University of Florida, Gainesville, FL, USA.

Zitieren

APA

Tracksdorf, T., Smith, D. M., Pearse, S., Cicali, E. J., Aquilante, C. L., Scott, S. A., Ho, T. T., Patel, J. N., Hicks, J. K., & Hertz, D. L. (2024). Strategies for DPYD testing prior to fluoropyrimidine chemotherapy in the US. Supportive Care in Cancer. https://doi.org/10.1007/s00520-024-08674-1

Vancouver

Tracksdorf T, Smith DM, Pearse S, Cicali EJ, Aquilante CL, Scott SA, et al. Strategies for DPYD testing prior to fluoropyrimidine chemotherapy in the US. Supportive Care in Cancer. 2024. doi:10.1007/s00520-024-08674-1

BibTeX
@article{Tracksdorf2024,
  author = {Tracksdorf, Tabea and Smith, D Max and Pearse, Skyler and Cicali, Emily J and Aquilante, Christina L and Scott, Stuart A and Ho, Teresa T and Patel, Jai N and Hicks, J Kevin and Hertz, Daniel L},
  title = {Strategies for DPYD testing prior to fluoropyrimidine chemotherapy in the US},
  journal = {Supportive Care in Cancer},
  year = {2024},
  doi = {10.1007/s00520-024-08674-1}
}
Kostenlos starten →